“Let the Algorithm Do the Work”: Reduction of Hypoglycemia Using Sensor-Augmented Pump Therapy with Predictive Insulin Suspension (SmartGuard) in Pediatric Type 1 Diabetes Patients

T. Biester,O. Kordonouri,M. Holder,Kerstin Remus,D. Kieninger-Baum,T. Wadien,T. Danne

DOI: https://doi.org/10.1089/dia.2016.0349

2017-03-01

Diabetes Technology & Therapeutics

Abstract:Abstract Background: A sensor-augmented insulin pump (SAP) using the MiniMed® 640G system with SmartGuard™ technology allows an automatic stop of insulin delivery based on prediction of low glucose levels. Since pediatric patients are particularly prone to hypoglycemia, this device may offer additional protection beyond conventional sensor-augmented therapy. Methods: This prospective, pediatric multicenter user evaluation assessed 6 weeks of SAP with SmartGuard (threshold setting for hypoglycemia: 70 mg/dL) compared to a preceding period of 2 weeks with SAP only. The primary outcome was the potential reduction in the frequency of hypoglycemic episodes and hypoglycemic intensity (area under the curve [AUC] and time <70 mg/dL). Results: The study included 24 patients with at least 3 months of insulin pump use (average age: 11.6 ± 5.1 years, 15 female, average type 1 diabetes duration: 7.5 ± 4.2 years, mean ± SD) who had on average 3.2 ± 1.0 predictive suspensions/patient/day. The mean sensor glucose minimum during suspension was 78 ± 6 mg/dL and the average suspension time was 155 ± 47 min/day. Use of SmartGuard in patients treated as per the protocol (n = 18) reduced the number of instances in which the glucose level was <70 mg/dL (1.02 ± 0.52 to 0.72 ± 0.36; P = 0.027), as well as AUC <70 mg/dL (0.76 ± 0.73 to 0.38 ± 0.24; P = 0.027) and the time/day the level fell below 70 mg/dL (73 ± 56 to 31 ± 22 min). The reduction of hypoglycemia was not associated with a significant change in mean glucose concentration (171 ± 26 to 180 ± 19 mg/dL, P = 0.111) and HbA1c (7.5% ± 0.5% to 7.6% ± 0.7%, (P = 0.329). Manual resumption of insulin delivery followed by carbohydrate intake resulted in significantly higher glucose levels 1 h after suspension compared to SmartGuard suspensions with automatic resume (190.8 ± 26.5 vs. 138.7 ± 10.3 mg/dL; P < 0.001). Conclusions: SmartGuard technology significantly reduced the risk for hypoglycemia in pediatric type 1 diabetes patients without increasing HbA1c. Patients must be educated that when using combining predictive low-glucose insulin suspension technology, extra carbohydrate intake in response to an alarm combined with manual resumption is likely to cause rebound hyperglycemia. The best results were achieved when the user did not interfere with pump operation.

What problem does this paper attempt to address?

This paper aims to solve the mechanism and energy problems of carbon monoxide (CO) adsorption on the surface of zirconia - supported copper (Cu/ZrO₂). Specifically, the main research objectives include:

1. **Calculate the adsorption energy of CO on zirconia - supported copper**: The author studied the adsorption behavior of CO on a monoxide layer (a monolayer of copper adsorbed on the cubic zirconia (111) surface) through first - principles calculations.

2. **Compare different structural zirconia phases**: The author calculated the structural parameters of three different zirconia phases (cubic, tetragonal, and monoclinic) and compared them with the experimental results to verify the accuracy of the theoretical model.

3. **Analyze the surface relaxation effect**: The surface relaxation of the cubic zirconia (111) surface under stoichiometric and reducing conditions (i.e., the removal of top - layer oxygen atoms) was studied, and the influence of these changes on the adsorption performance was discussed.

4. **Determine the optimal binding site of copper**: By calculating the binding energy of copper at different high - symmetry positions (top - oxygen site, triple - vacancy site, and subsurface - oxygen site), it was determined that the optimal binding site of copper on the zirconia (111) surface is the top - oxygen site (O₁), and its binding energy is approximately 0.3 eV/atom higher than that of other sites.

5. **Compare the adsorption of CO on zirconia - supported copper and pure copper (100) surfaces**: The results show that the adsorption energy of CO on zirconia - supported copper is approximately 0.2 eV higher than that on pure copper (100) surfaces. This may be due to the enhanced charge transfer from copper atoms to the zirconia substrate, which strengthens the adsorption of CO.

### Formula Summary

- **Adsorption Energy Difference**:
\[
E_{\text{ads}}^{\text{Cu/ZrO}_2}-E_{\text{ads}}^{\text{Cu(100)}}\approx0.2\,\text{eV}
\]

- **Binding Energy of Copper at Different Sites**:
\[
E_{\text{bind}}^{\text{O1}} = 1.8\,\text{eV/atom},\quad E_{\text{bind}}^{\text{Zr}} = 1.5\,\text{eV/atom},\quad E_{\text{bind}}^{\text{O2}} = 1.3\,\text{eV/atom}
\]

- **Binding Energy of CO on Cu/ZrO₂ and Cu(100)**:
\[
E_{\text{bind}}^{\text{CO - Cu - ZrO}_2}=0.86\,\text{eV},\quad E_{\text{bind}}^{\text{CO - Cu(100)}} = 0.65\,\text{eV}
\]

### Conclusion

This study shows that zirconia - supported copper has excellent catalytic activity at low temperatures, especially in NO reduction and CO oxidation reactions. In addition, the presence of the zirconia substrate significantly enhances the adsorption stability of CO molecules on the copper surface, which is of great significance for the development of a new generation of automotive catalysts.